Much of the initially flat‐​footed response of public health officials to the coronavirus pandemic was due to cumbersome, inflexible, and outdated regulations controlling the development and distribution of drugs and tests. It is important that policymakers recognize the regulatory obstacles that have accumulated over the years that make our system less nimble in responding to unexpected events, and work to reform those laws.